A Randomized, Double-blind, Controlled, Stepwise Titration Study to Evaluate Dose Response to Prandial Administration of Inhaled Technosphere/Insulin or Technosphere in Patients With Type 2 Diabetes Mellitus Who Are Sub-optimally Treated.
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2012
At a glance
- Drugs Insulin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors MannKind Corporation
- 31 Aug 2018 Biomarkers information updated
- 27 Apr 2012 Actual patient number 227 added as reported by ClinicalTrials.gov.
- 27 Apr 2012 Actual end date Aug 2007 added as reported by ClinicalTrials.gov.